Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (121-130 of 917) with videos related to

Pageof 92
Sort By:
Urologic Oncology|June 7, 2021
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume centerChristoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
The Journal of Urology|December 11, 2003
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancerHerbert Augustin, Thilo Eggert, Sven Wenske, et al.
European Urology Focus|July 30, 2017
Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Katharina Bogdan, et al.
European Urology|March 21, 2017
Low-risk Prostate Cancer: Identification, Management, and OutcomesMarco Moschini, Peter R Carroll, Scott E Eggener, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
BJU International|May 26, 2021
Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionRandi M Pose, Sophie Knipper, Christoph Würnschimmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for stagingHerbert Augustin, Markus Graefen, Jüri Palisaar, et al.
World Journal of Urology|November 16, 2024
Impact of the time interval between biopsy and radical prostatectomy on functional outcomesRosannis Brown, Burkhard Beyer, Sophie Knipper, et al.
Cancer|June 8, 2021
Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancerDaniel W Kim, Ming-Hui Chen, Jing Wu, et al.
The Prostate|June 8, 2021
Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table dataChristoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Pageof 92

Showing results (121-130 of 917) with videos related to

Sort By:
Pageof 92
Urologic Oncology|June 7, 2021
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume centerChristoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
The Journal of Urology|December 11, 2003
Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancerHerbert Augustin, Thilo Eggert, Sven Wenske, et al.
European Urology Focus|July 30, 2017
Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Katharina Bogdan, et al.
European Urology|March 21, 2017
Low-risk Prostate Cancer: Identification, Management, and OutcomesMarco Moschini, Peter R Carroll, Scott E Eggener, et al.
European Urology Focus|July 28, 2018
Accuracy of <sup>68</sup>Ga-Prostate-specific Membrane Antigen Positron Emission Tomography for the Detection of Lymph Node Metastases Before Salvage LymphadenectomyPhilipp Mandel, Derya Tilki, Felix K Chun, et al.
BJU International|May 26, 2021
Significant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionRandi M Pose, Sophie Knipper, Christoph Würnschimmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for stagingHerbert Augustin, Markus Graefen, Jüri Palisaar, et al.
World Journal of Urology|November 16, 2024
Impact of the time interval between biopsy and radical prostatectomy on functional outcomesRosannis Brown, Burkhard Beyer, Sophie Knipper, et al.
Cancer|June 8, 2021
Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancerDaniel W Kim, Ming-Hui Chen, Jing Wu, et al.
The Prostate|June 8, 2021
Long-term overall survival of radical prostatectomy patients is often superior to the general population: A comparison using life-table dataChristoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Pageof 92